Congenital Hemangioma Involution

Biological Characteristics

Congenital hemangiomas are fully formed and present at birth, having completed their entire proliferative phase during fetal development 1, 3
They do not exhibit postnatal proliferation, which is the hallmark characteristic that distinguishes them from infantile hemangiomas 1, 4
They lack GLUT1 expression, a key immunohistochemical marker that differentiates them from infantile hemangiomas at the molecular level 1, 2

Rapidly involuting congenital hemangiomas (RICH) undergo rapid involution beginning in the first year of life, with most regression occurring during the first 12-30 months 1, 2
The involution process involves progressive apoptosis of endothelial cells and pericytes, with mitotic figures waning and apoptotic bodies increasing 5
Lesional capillaries progressively disappear without thrombosis or significant inflammation 5
The basement membranes become thick and hyalinized, containing apoptotic debris as involution proceeds 5
Eventually, only loose fibrous or fibrofatty stroma remains with residual "ghost" vessels composed of thickened basement membrane material 5

Involution typically begins between 6-12 months of age for RICH 5
The lesions flatten and shrink from the center outward, with central clearing or graying of the surface 5
Most tumor regression occurs before age 4 years 5
RICH may be associated with transient thrombocytopenia and rarely congestive heart failure during the involution phase 1, 2

Infantile hemangiomas proliferate postnatally (up to 12 months), then involute over years 5
Congenital hemangiomas complete proliferation in utero, so they are either programmed to involute immediately (RICH) or remain stable (NICH) 1, 4
This represents fundamentally different biological behavior, not just different timing of the same process 1, 3